Amend, C. et al. 2025. Induced Antileukemic Activity after Blast Modulation is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells. Archives of Clinical and Biomedical Research. 9, 6 (Dec. 2025), 521–541.